文献速递分子诊断临床微生物质量管理与危急值

呼吸道病毒快速分子诊断对住院成人结局的影响:多中心准实验研究

Impact of Rapid Molecular Diagnostic Testing of Respiratory Viruses on Outcomes of Adults Hospitalized with Respiratory Illness: a Multicenter Quasi-experimental Study.
PubMed 文献 · J Clin Microbiol · 2019-03-28

该多中心准实验研究在澳大利亚三家医院评估快速PCR(Cepheid Xpert Flu/RSV XC)对住院成人呼吸道疾病患者结局的影响。结果显示,快速PCR与阳性患者中位住院时间显著缩短21.5小时相关,并显著减少血培养、痰培养及细菌和病毒血清学检测的使用,但尿培养无显著变化。

要点

  • 快速PCR使阳性患者中位住院时间显著缩短21.5小时。
  • 快速PCR显著减少血培养、痰培养及细菌和病毒血清学检测。
  • 尿培养使用无显著减少,总体住院时间缩短未达统计学显著。

核心结论

  • 快速PCR检测可缩短阳性患者住院时间并减少资源利用。

研究设计与样本

  • 在澳大利亚新南威尔士州三家医院开展的对照准实验研究。
  • 干预组:实施前(2016年7-12月)标准多重PCR n=953,实施后(2017年7-12月)快速PCR n=1209。
  • 对照组:同期随机选取的住院成人呼吸道疾病患者,实施前n=937,实施后n=1102。

主要发现

  • 所有患者中位住院时间缩短8.9小时(95%CI -21.5至3.7小时;P=0.17),无统计学意义。
  • 阳性患者中位住院时间显著缩短21.5小时(95%CI -36.8至-6.2小时;P<0.01)。
  • 出院前获得结果的患者中,快速PCR与住院时间显著缩短相关,与检测结果无关。
  • 与标准PCR相比,快速PCR显著减少血培养(aOR 0.67;95%CI 0.5-0.82;P<0.001)、痰培养(aOR 0.56;95%CI 0.47-0.68;P<0.001)、细菌血清学(aOR 0.44;95%CI 0.35-0.55;P<0.001)和病毒血清学(aOR 0.42;95%CI 0.33-0.53;P<0.001)检测。
  • 尿培养检测无显著减少(aOR 0.94;95%CI 0.78-1.12;P=0.48)。

临床怎么用

  • 对住院呼吸道疾病成人采用快速PCR检测可能缩短阳性患者住院时间并减少部分微生物学检测。

局限性

  • 未来研究需进行正式的经济学分析并评估对临床决策的潜在影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A standard multiplex PCR offers comprehensive testing for respiratory viruses. However, it has traditionally been performed in a referral laboratory with a lengthy turnaround time, which can reduce patient flow through the hospital. We aimed to determine whether the introduction of a rapid PCR, but with limited targets (Cepheid Xpert Flu/RSV XC), was associated with improved outcomes for adults hospitalized with respiratory illness. A controlled quasi-experimental study was conducted across three hospitals in New South Wales, Australia. Intervention groups received standard multiplex PCR during the preimplementation, July to December 2016 (n = 953), and rapid PCR during the postimplementation, July to December 2017 (n = 1,209). Control groups (preimplementation, n = 937, and postimplementation, n = 1,102) were randomly selected from adults hospitalized with respiratory illness during the same periods. The outcomes were hospital length of stay (LOS) and microbiology test utilization (blood culture, urine culture, sputum culture, and respiratory bacterial and virus serologies). The introduction of rapid PCR was associated with a nonsignificant 8.9-h reduction in median LOS (95% confidence interval [CI], -21.5 h to 3.7 h; P = 0.17) for all patients and a significant 21.5-h reduction in median LOS (95% CI, -36.8 h to -6.2 h; P < 0.01) among patients with positive test results in an adjusted difference-in-differences analysis. For patients receiving test results before disposition, rapid PCR use was associated with a significant reduction in LOS, irrespective of test results. Compared with standard PCR testing, rapid PCR use was significantly associated with fewer blood culture (adjusted odds ratio [aOR], 0.67; 95% CI, 0.5 to 0.82; P < 0.001), sputum culture (aOR, 0.56; 95% CI, 0.47 to 0.68, P < 0.001), bacterial serology (aOR, 0.44; 95% CI, 0.35 to 0.55, P < 0.001) and viral serology (aOR, 0.42; 95% CI, 0.33 to 0.53, P < 0.001) tests, but not with fewer urine culture tests (aOR, 0.94; 95% CI, 0.78 to 1.12, P = 0.48). Rapid PCR testing of adults hospitalized with respiratory illnesses can deliver benefits to patients and reduce resource utilization. Future research should consider a formal economic analysis and assess its potential impacts on clinical decision making.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Wabe N, Li L, Lindeman R, et al. Impact of Rapid Molecular Diagnostic Testing of Respiratory Viruses on Outcomes of Adults Hospitalized with Respiratory Illness: a Multicenter Quasi-experimental Study. J Clin Microbiol. 2019. PMID: 30541934. doi:10.1128/JCM.01727-18

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。